lung transplant outcomes. We implemented a perioperative strategy to treat DSA-positive
recipients, leading to equivalent rejection and graft survival outcomes. Pretransplant DSA
were identified to HLA-A, B, C, DR and DQ antigens. DSA-positive patients were
transplanted if panel reactive antibody (PRA)≥ 30% or medically urgent and desensitized
with perioperative plasma exchange, intravenous immune globulin, antithymocyte globulin …